Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.
J Natl Cancer Inst
; 108(5)2016 May.
Article
in En
| MEDLINE
| ID: mdl-26615020
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzimidazoles
/
DNA Modification Methylases
/
Antineoplastic Combined Chemotherapy Protocols
/
Glioblastoma
/
DNA Methylation
/
Tumor Suppressor Proteins
/
Dacarbazine
/
DNA Repair Enzymes
/
Poly(ADP-ribose) Polymerase Inhibitors
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Natl Cancer Inst
Year:
2016
Type:
Article